Allscripts Healthcare Solutions, Inc. - common stock (MDRX): Price and Financial Metrics


Allscripts Healthcare Solutions, Inc. - common stock (MDRX): $17.08

-0.15 (-0.87%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

MDRX POWR Grades


  • Growth is the dimension where MDRX ranks best; there it ranks ahead of 98.62% of US stocks.
  • The strongest trend for MDRX is in Momentum, which has been heading down over the past 31 weeks.
  • MDRX ranks lowest in Sentiment; there it ranks in the 21st percentile.

MDRX Stock Summary

  • MDRX's current price/earnings ratio is 3.34, which is higher than only 2.51% of US stocks with positive earnings.
  • With a year-over-year growth in debt of -76.32%, Allscripts Healthcare Solutions Inc's debt growth rate surpasses merely 3.76% of about US stocks.
  • Over the past twelve months, MDRX has reported earnings growth of -521.21%, putting it ahead of only 3.76% of US stocks in our set.
  • If you're looking for stocks that are quantitatively similar to Allscripts Healthcare Solutions Inc, a group of peers worth examining would be LBRT, YCBD, PMD, SAFM, and INTZ.
  • MDRX's SEC filings can be seen here. And to visit Allscripts Healthcare Solutions Inc's official web site, go to www.allscripts.com.

MDRX Valuation Summary

  • MDRX's EV/EBIT ratio is 3; this is 90.98% lower than that of the median Technology stock.
  • Over the past 243 months, MDRX's price/sales ratio has gone down 2.4.
  • Over the past 243 months, MDRX's price/sales ratio has gone down 2.4.

Below are key valuation metrics over time for MDRX.

Stock Date P/S P/B P/E EV/EBIT
MDRX 2016-05-24 1.8 1.8 249.6 65.8
MDRX 2012-09-18 1.3 1.5 32.1 20.2
MDRX 2011-08-29 2.5 2.3 143.8 56.3
MDRX 2008-06-13 2.5 2.1 45.0 29.4
MDRX 2006-05-25 6.8 3.2 95.5 69.5
MDRX 2003-09-30 2.0 1.9 -16.7 -14.9

MDRX Growth Metrics

  • The year over year net income to common stockholders growth rate now stands at 474.31%.
  • Its 2 year net cashflow from operations growth rate is now at -85.99%.
  • Its 2 year cash and equivalents growth rate is now at 47.55%.
MDRX's revenue has moved down $551,940,000 over the prior 34 months.

The table below shows MDRX's growth in key financial areas (numbers in millions of US dollars).

Date Revenue Operating Cash Flow Net Income to Common Stock
2021-03-31 1,454.339 -98.432 729.818
2020-12-31 1,502.7 -106.715 700.407
2020-09-30 1,675.95 84.215 -46.387
2020-06-30 1,718.104 67.102 -52.654
2020-03-31 1,756.341 36.73 -194.979
2019-12-31 1,771.677 46.254 -182.178

MDRX Price Target

For more insight on analysts targets of MDRX, see our MDRX price target page. And for a list of of all stocks sorted by upside potential based on analyst target price, see our Top Price Target page.

Average Price Target $17.29 Average Broker Recommendation 1.76 (Moderate Buy)

MDRX Stock Price Chart Interactive Chart >

Price chart for MDRX

MDRX Price/Volume Stats

Current price $17.08 52-week high $19.00
Prev. close $17.23 52-week low $7.55
Day low $17.02 Volume 1,177,600
Day high $17.31 Avg. volume 1,725,944
50-day MA $17.79 Dividend yield N/A
200-day MA $15.54 Market Cap 2.41B

Allscripts Healthcare Solutions, Inc. - common stock (MDRX) Company Bio


AllScripts Healthcare Solutions provides clinical, financial, electronic health records (EHR), connectivity, hosting, outsourcing, analytics, patient engagement, and population health products and services in the United States and Canada. It operates in three segments: Clinical and Financial Solutions, Population Health, and Managed Services. The company was founded in 1986 and is based in Chicago, Illinois.


MDRX Latest News Stream


Event/Time News Detail
Loading, please wait...

MDRX Latest Social Stream


Loading social stream, please wait...

View Full MDRX Social Stream

Latest MDRX News From Around the Web

Below are the latest news stories about Allscripts Healthcare Solutions Inc that investors may wish to consider to help them evaluate MDRX as an investment opportunity.

AllScripts Healthcare (MDRX) to Report Q2 Results: What to Know Ahead of the Release

AllScripts (MDRX) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Yahoo | July 22, 2021

Allscripts to Release Second-Quarter 2021 Financial Results August 5

CHICAGO, July 22, 2021--Allscripts Healthcare Solutions, Inc. (Nasdaq:MDRX) will report its financial results for the three months ended June 30, 2021 after the close of stock market hours on Thursday, August 5, 2021. Allscripts management plans to host a conference call and webcast to discuss the company's earnings at 4:30 p.m. Eastern Time that same day.

Yahoo | July 22, 2021

Best Report on Digital Innovations In Healthcare Market by 2021-2026 Focusing on Leading Players Cerner Corporation, Allscripts, Apple, Inc., Telefónica S.A

The global Digital Innovations In Healthcare market size was valued at USD 96.5 billion in 2020 and is expected to grow at a compound annual growth rate (CAGR) of 15.1% from 2021 to 2026. Digital Innovations In Healthcare Market report is

OpenPR | July 20, 2021

CareCloud: The (Cheap) King Of Healthcare SaaS

ipopba/iStock via Getty Images Investment Thesis CareCloud (NASDAQ: MTBC) is a cheap, great growth stock. Its product offering, through acquisitions, enhancement, and operating efficiencies, has become attractive both in price and quality aspect, and fit the needs of customers in the large, high-growth healthcare IT market. While this makes me...

Konrad van Kempen on Seeking Alpha | July 19, 2021

Hedge Funds Are Nibbling On Allscripts Healthcare Solutions Inc (MDRX)

No summary available.

Insider Monkey | July 19, 2021

Read More 'MDRX' Stories Here

MDRX Price Returns

1-mo -7.07%
3-mo 4.98%
6-mo 2.15%
1-year 89.78%
3-year 35.66%
5-year 22.26%
YTD 18.28%
2020 47.12%
2019 1.82%
2018 -33.75%
2017 42.51%
2016 -33.62%

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!


Page generated in 0.8162 seconds.